Total Payments
$282,196
2024 Payments
$30,274
Companies
22
Transactions
1,120
Medicare Patients
634
Medicare Billing
$50,020
Payment Breakdown by Category
Other$239,981 (85.0%)
Food & Beverage$18,094 (6.4%)
Travel$17,123 (6.1%)
Consulting$6,643 (2.4%)
Education$356.35 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $239,981 | 132 | 85.0% |
| Food and Beverage | $18,094 | 847 | 6.4% |
| Travel and Lodging | $17,123 | 128 | 6.1% |
| Consulting Fee | $6,643 | 3 | 2.4% |
| Education | $356.35 | 10 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $110,684 | 208 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $65,928 | 181 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $59,311 | 134 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $12,817 | 130 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $12,161 | 41 | $0 (2021) |
| Allergan, Inc. | $8,720 | 89 | $0 (2020) |
| ITI, Inc. | $7,497 | 34 | $0 (2023) |
| ABBVIE INC. | $1,712 | 107 | $0 (2024) |
| Lundbeck LLC | $904.56 | 60 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $785.45 | 44 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $30,274 | 91 | Teva Pharmaceuticals USA, Inc. ($20,474) |
| 2023 | $32,698 | 110 | Otsuka America Pharmaceutical, Inc. ($11,351) |
| 2022 | $28,278 | 135 | Otsuka America Pharmaceutical, Inc. ($15,950) |
| 2021 | $36,941 | 204 | Alkermes, Inc. ($20,111) |
| 2020 | $23,345 | 142 | Teva Pharmaceuticals USA, Inc. ($8,423) |
| 2019 | $81,002 | 222 | Alkermes, Inc. ($36,494) |
| 2018 | $30,033 | 125 | Alkermes, Inc. ($14,782) |
| 2017 | $19,625 | 91 | Alkermes, Inc. ($11,895) |
All Payment Transactions
1,120 individual payment records from CMS Open Payments — Page 1 of 45
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: PSYCHIATRY | ||||||
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $13.21 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/03/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: Neuroscience | ||||||
| 11/26/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $11.05 | General |
| Category: PSYCHIATRY | ||||||
| 11/21/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $22.52 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/19/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: PSYCHIATRY | ||||||
| 11/14/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,100.00 | General |
| Category: Neurology | ||||||
| 11/14/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Travel and Lodging | Cash or cash equivalent | $20.10 | General |
| Category: Neurology | ||||||
| 11/12/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $27.35 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/12/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: PSYCHIATRY | ||||||
| 11/11/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $17.53 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/07/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $22.02 | General |
| Category: CNS | ||||||
| 11/05/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: Neuropsychiatry | ||||||
| 10/29/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $10.19 | General |
| Category: PSYCHIATRY | ||||||
| 10/24/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,106.00 | General |
| Category: PSYCHIATRY | ||||||
| 10/23/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $4.30 | General |
| Category: PSYCHIATRY | ||||||
| 10/22/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $9.36 | General |
| Category: PSYCHIATRY | ||||||
| 10/17/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $117.81 | General |
| Category: PSYCHIATRY | ||||||
| 10/11/2024 | Teva Pharmaceuticals USA, Inc. | — | Education | In-kind items and services | $111.49 | General |
| 09/26/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: Neurology | ||||||
| 09/10/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $11.34 | General |
| Category: PSYCHIATRY | ||||||
| 09/05/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: CNS | ||||||
| 08/29/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $11.11 | General |
| Category: PSYCHIATRY | ||||||
| 08/27/2024 | Lundbeck LLC | ABILIFY ASIMTUFII (Drug) | Food and Beverage | Cash or cash equivalent | $13.46 | General |
| Category: PSYCHIATRY | ||||||
| 08/21/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $877.50 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 30 | 187 | $8,300 | $5,392 |
| 2022 | 6 | 176 | 493 | $21,210 | $10,594 |
| 2021 | 5 | 154 | 433 | $23,980 | $14,262 |
| 2020 | 8 | 274 | 650 | $38,430 | $19,772 |
Total Patients
634
Total Services
1,763
Medicare Billing
$50,020
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 18 | 145 | $7,250 | $5,298 | 73.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Facility | 2023 | 12 | 42 | $1,050 | $94.05 | 9.0% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 31 | 112 | $5,600 | $3,191 | 57.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 14 | 22 | $2,750 | $2,005 | 72.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Facility | 2022 | 69 | 273 | $6,825 | $1,940 | 28.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 19 | 19 | $2,660 | $1,915 | 72.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 17 | 17 | $2,125 | $1,334 | 62.8% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Facility | 2022 | 26 | 50 | $1,250 | $208.53 | 16.7% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 35 | 171 | $8,550 | $4,985 | 58.3% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 27 | 32 | $4,480 | $3,287 | 73.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 14 | 25 | $3,125 | $2,367 | 75.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 24 | 27 | $3,375 | $2,169 | 64.3% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Facility | 2021 | 54 | 178 | $4,450 | $1,454 | 32.7% |
| 90834 | Psychotherapy, 45 minutes | Office | 2020 | 27 | 61 | $5,205 | $3,694 | 71.0% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 32 | 120 | $6,100 | $3,612 | 59.2% |
| 90834 | Psychotherapy, 45 minutes | Facility | 2020 | 56 | 88 | $7,620 | $3,471 | 45.5% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 19 | 19 | $2,840 | $1,997 | 70.3% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Facility | 2020 | 53 | 257 | $6,425 | $1,801 | 28.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 16 | 17 | $2,125 | $1,396 | 65.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 16 | 22 | $2,715 | $1,377 | 50.7% |
| 90832 | Psychotherapy, 30 minutes | Office | 2020 | 21 | 28 | $1,830 | $955.15 | 52.2% |
| 90791 | Psychiatric diagnostic evaluation | Facility | 2020 | 12 | 12 | $1,810 | $755.83 | 41.8% |
| 90832 | Psychotherapy, 30 minutes | Facility | 2020 | 22 | 26 | $1,760 | $713.50 | 40.5% |
About Dr. Eric Jaggers, MD
Dr. Eric Jaggers, MD is a Psychiatry healthcare provider based in Jeffersonville, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/08/2007. The National Provider Identifier (NPI) number assigned to this provider is 1902954357.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Jaggers, MD has received a total of $282,196 in payments from pharmaceutical and medical device companies, with $30,274 received in 2024. These payments were reported across 1,120 transactions from 22 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($239,981).
As a Medicare-enrolled provider, Jaggers has provided services to 634 Medicare beneficiaries, totaling 1,763 services with total Medicare billing of $50,020. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Jeffersonville, IN
- Active Since 01/08/2007
- Last Updated 07/08/2007
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1902954357
Products in Payments
- ARISTADA (Drug) $83,866
- ABILIFY MAINTENA (Drug) $59,302
- AUSTEDO (Drug) $33,042
- Aristada 441 mg (Drug) $26,654
- Austedo XR (Drug) $18,970
- LATUDA (Drug) $12,161
- SPRAVATO (Drug) $11,630
- VRAYLAR (Drug) $10,432
- CAPLYTA (Drug) $7,689
- UZEDY (Drug) $7,065
- ABILIFY ASIMTUFII (Drug) $5,584
- REXULTI (Drug) $1,828
- INVEGA SUSTENNA (Drug) $1,000
- INGREZZA (Drug) $785.45
- HETLIOZ (Drug) $471.66
- PERSERIS (Drug) $277.54
- Auvelity (Drug) $207.59
- INVEGA TRINZA (Drug) $186.25
- LYBALVI (Drug) $127.73
- TRINTELLIX (Drug) $107.97
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Jeffersonville
Dr. Irfan Afaq, M.d, M.D
Psychiatry — Payments: $13,798
Psychiatry $13,798
Leah Dickerson, Md, MD
Psychiatry — Payments: $9,010
Psychiatry $9,010
Mary Bouldin, M.d, M.D
Psychiatry — Payments: $4,903
Psychiatry $4,903
Steven Gibson, Md, MD
Psychiatry — Payments: $4,198
Psychiatry $4,198
Geoffrey Jeyasingham
Psychiatry — Payments: $3,332
Psychiatry $3,332
Carol Hammerbeck
Psychiatry — Payments: $2,090
Psychiatry $2,090